2023 Annual Meeting | S11 - Practice, Policy, and Ethics
11:15 AM - 11:27 AM EST | Abstract |
001 - Multi-Centre Audit Of Myotonic Dystrophy In the UK: How Can We Improve Access to Care?
Channa A. Hewamadduma, MBBS, PhD, FRCP, MSc |
11:27 AM - 11:39 AM EST | Abstract |
002 - Epilepsy Quality Performance Over Time: A National Veterans Health Administration Quality Improvement Study
Hamada H. Altalib, DO |
11:39 AM - 11:51 AM EST | Abstract |
003 - Clinically Designed Improvisatory Music Interventions for Well-Being and Burnout Prevention for Neurology, Psychiatry, and Other Health Professionals: Preliminary Findings
Clara Takarabe |
11:51 AM - 12:03 PM EST | Abstract |
004 - Documentation of Thrombolytic Therapy Consent in Acute Ischemic Stroke
Alexis Kaiser, MD |
12:03 PM - 12:15 PM EST | Abstract |
005 - Ethically Translating Novel Neurotechnologies for Detecting Covert Consciousness: Clinician Perspectives from an Interim Analysis of the DECODE Study
Michael Young, MD |
Leigh R. Hochberg, MD, PhD, FAAN | The institution of Dr. Hochberg has received research support from The MGH Translational Research Center has a clinical research support agreement (CRSA) with Axoft, Neuralink, Neurobionics, Precision Neuro, Synchron, and Reach Neuro, for which LRH provides consultative input. LRH is a non-compensated member of the Board of Directors of a nonprofit assistive communication device technology foundation (Speak Your Mind Foundation). Mass General Brigham (MGB) is convening the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC); charitable gift agreements to MGB, including those received to date from Paradromics, Synchron, Precision Neuro, Neuralink, and Blackrock Neurotech, support the iBCI-CC, for which LRH provides effort.. The institution of Dr. Hochberg has received research support from Dr. Hochberg also receives research support from the US Department of Veterans Affairs and the National Institutes of Health.. Dr. Hochberg has received intellectual property interests from a discovery or technology relating to health care. |
David Q. Beversdorf, MD, FAAN | Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors. |
Sarah J. Hon, DO, MBA, FAAN | Dr. Hon has received personal compensation for serving as an employee of Kansas City Clinical Neuroscience Society. |
Joel I. Shenker, MD, PhD, FAAN | Dr. Shenker has received personal compensation for serving as an employee of R3 continuum. Dr. Shenker has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for attorneys. |
Sharyl R. Martini, MD, PhD | Dr. Martini has nothing to disclose. |
Hamada H. Altalib, DO | The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from Eisai. The institution of Dr. Altalib has received research support from Sunovian. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS. |
No disclosure on file | |
Mary Jo Pugh, PhD, RN, FAAN | The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi. |
Brian Edlow, MD | Dr. Edlow has received research support from NIH. |
Borna Bonakdarpour, MD, FAAN | Dr. Bonakdarpour has nothing to disclose. |
Channa A. Hewamadduma, MBBS, PhD, FRCP, MSc | Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARENX. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Hewamadduma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Hewamadduma has received research support from Neurocare . The institution of Dr. Hewamadduma has received research support from Sheffield Charitable Trust. Dr. Hewamadduma has received personal compensation in the range of $5,000-$9,999 for serving as a Adult Expert with National Health Service England (NHSE). |
Evan Templeton, MD | Dr. Templeton has nothing to disclose. |
Yelena Bodien, PhD | Dr. Bodien has nothing to disclose. |
Michael Young, MD | Dr. Young has nothing to disclose. |
James B. Lilleker, MBChB | Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. |
Frederick Vonberg, MBBS | Dr. Vonberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prova Health. |
Helen E. Grote, MBBS, PhD | Dr. Grote has nothing to disclose. |
Alexis Kaiser, MD | Dr. Kaiser has nothing to disclose. |
Brian M. Wall, MD | Dr. Wall has nothing to disclose. |
Mahjabin Islam, MBBS, MRCP( UK ) | Dr. Islam has nothing to disclose. |
Sadaf Mehboob, MBBS | Dr. Mehboob has nothing to disclose. |
Clara Takarabe | Ms. Takarabe has nothing to disclose. |
Margaret Gopaul, PhD | Dr. Gopaul has nothing to disclose. |
Phillip Kelly | No disclosure on file |